Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Keep Your Eye on the Ball !
View:
Post by Oden6570 on Jun 29, 2024 8:18am

Keep Your Eye on the Ball !

The study has treated 63 patients so far, with interim data showing a complete response rate of 64% at the primary assessment, exceeding the International Bladder Cancer Group's (IBCG) guidelines of a 50% response rate at 6 months.

Update on Theralase's Phase II NMIBC Clinical Trial (patsnap.com)
Comment by chry200030 on Jun 29, 2024 8:34am
Better to buy and hold now at these prices as it's just a matter of time that TLT will rocket. It's no longer an IF but a WHEN... Good luck.
Comment by Alamir1111 on Jun 29, 2024 2:09pm
Celsius  market cap was around 190 mil https://news.abbvie.com/2024-06-27-AbbVie-Acquires-Celsius-Therapeutics
Comment by Alamir1111 on Jun 29, 2024 2:36pm
At a 49 mill market a 250 mill offer would be huge
Comment by menoalittle on Jun 29, 2024 2:49pm
There's no way an all cash offer like that would be successful in a hostile takeover bid that low.
Comment by Alamir1111 on Jun 29, 2024 2:59pm
What is hostile about 5× ?
Comment by menoalittle on Jun 29, 2024 3:56pm
Any offer not acceptable and not recommended by the Board iof Directors is considered hostile.  If you think that sort of offer is something Roger would accept, then that says a lot about what you don't know about this company....
Comment by Alamir1111 on Jun 29, 2024 4:03pm
Small piggy little piggy Personally, I think the stock is getting a little too ripe for a hostile takeover bid. If put together and done sharply, I suspect it might suceed a little easier that some think... but, what do I know.  
Comment by Alamir1111 on Jun 29, 2024 4:21pm
Yes Meno little quote 
Comment by Alamir1111 on Jun 29, 2024 3:17pm
Meno a accredited investor is a person's who got 1 mill in assets  including real estate
Comment by menoalittle on Jun 29, 2024 3:32pm
Not so, it excludes your residence (which is the only real estate most people own.)
Comment by menoalittle on Jun 29, 2024 3:37pm
Furthermore, it's the assets net value, meaning after all liabilities against the assets are subtracted.
Comment by Alamir1111 on Jun 29, 2024 3:43pm
Renting in a mill property or living in relatives basement don't count  
Comment by Alamir1111 on Jun 29, 2024 3:50pm
Hey Meno just go get some warrants talk to Matthew p
Comment by menoalittle on Jun 29, 2024 3:58pm
What makes you so sure I don't already have warrants, or that I don't know what I'm talking about?
Comment by Alamir1111 on Jun 29, 2024 4:08pm
Sorry bro you ain't got no gas
Comment by Johnandrose22 on Jun 29, 2024 2:51pm
I would also think that the data posted on this morning's Phase II summary correlates to the data of the FDA approved Central Lab giving added weight and credibility to the findings thus far. Yes...not If..but when!
Comment by Alamir1111 on Jun 29, 2024 3:02pm
Johnan Where was fda approved central lab ever mentioned  ??
Comment by Johnandrose22 on Jun 29, 2024 4:08pm
The notes taken from the recent AGM make clear that the FDA "insisted" that the company's Phase II data be confirmed via an FDA approved Central Lab...much to the apparent annoyance of the CEO. However, Mr White was candid in concluding that it is the FDA who makes the rules. For the company, just a few days after the AGM, to publish its current extraordinary findings as it did this ...more  
Comment by Alamir1111 on Jun 29, 2024 4:14pm
This post has been removed in accordance with Community Policy
Comment by Oilminerdeluxe on Jun 29, 2024 4:21pm
If the data has been confirmed, that would be sweet indeed. How long would such a process take? Bureaucracy is what it is.
Comment by plantrader on Jun 29, 2024 4:48pm
John, Did the company put out a PII update this morning on a Saturday, or did some 3rd party article hit the internet today that rehashes and summarizes the PII results update that the company put out on May 30th?
Comment by Johnandrose22 on Jun 29, 2024 5:00pm
Interesting point...and worth clarifying. However, would even the May 30th data been processed and validated by an FDA Central Lab? It seems the FDA's requirement goes back some time.
Comment by plantrader on Jun 29, 2024 5:11pm
John, I don't know for sure. But I don't think the May 30th update was based on the central path lab analysis, as far as I know. If I'm wrong I'm sure someone can clarify. But didn't RDW say at the annual meeting in mid June 2024 that the central path lab data had finally started to come in? Or maybe he was more ambiguous and simply said the additional data that the FDA ...more  
Comment by johannn on Jun 29, 2024 6:16pm
Keep your eye on the prize!
Comment by Legit62 on Jun 29, 2024 6:48pm
I dont think we know for sure what the  date of that info is, just like we dont know results of recent PP. I would also think that would be a bigger NR , and not on a saturday
Comment by gonefishing2022 on Jun 29, 2024 8:22pm
No News Until Probly Tuesday Morning and My Guess is they Rasied just under a Million Again. Enough to get them Money to BTD It's going to be a slow Ride until September or October. 
Comment by Legit62 on Jun 30, 2024 12:01pm
Im betting we got 5 mil, Roger would look like a fool looking for 10mil and pulling in 1, he had to have a few big investors lined up to look for 10 mil IMO i guess we find out this week
Comment by Oilminerdeluxe on Jun 30, 2024 12:30pm
I'll go with 2,1. With Roger as a big contributor. As long as it lasts s to BTD, it's all good no matter the seize.
Comment by Oilminerdeluxe on Jun 30, 2024 12:45pm
size
Comment by Alamir1111 on Jun 30, 2024 12:58pm
He's making half of mii  salary don't see much of a contributor   to pp
Comment by N0taP00p on Jun 30, 2024 1:35pm
Raising $5M would renew the faith and fill the church with believers again.
Comment by menoalittle on Jun 30, 2024 2:29pm
As stated previously, I'n not betting (aka, buying) anything until the placement is closed...
Comment by Alamir1111 on Jun 30, 2024 5:22pm
What  a pitty co fortunes depend on you.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250